Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | -1.56% | +4.13% | -31.52% |
Apr. 09 | Biodesix, Inc. announced that it has received $34.999422 million in funding | CI |
Apr. 05 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 65.25M | Sales 2025 * | 79.05M | Capitalization | 143M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -32M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.81 x |
P/E ratio 2024 * |
-3.15
x | P/E ratio 2025 * |
-4.13
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.56% |
Latest transcript on Biodesix, Inc.
1 day | -1.56% | ||
1 week | +4.13% | ||
Current month | -11.89% | ||
1 month | -8.70% | ||
3 months | -37.31% | ||
6 months | -17.11% | ||
Current year | -31.52% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.26 | -1.56% | 7,101 |
24-04-23 | 1.28 | -0.78% | 36,906 |
24-04-22 | 1.29 | +3.20% | 48,595 |
24-04-19 | 1.25 | 0.00% | 47,678 |
24-04-18 | 1.25 | +3.31% | 45,441 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.52% | 143M | |
-16.65% | 8.34B | |
+39.98% | 3.59B | |
-32.00% | 2.75B | |
-7.71% | 2.48B | |
-9.55% | 2.32B | |
-13.29% | 1.79B | |
-19.46% | 1.54B | |
-40.57% | 1.21B | |
+9.70% | 1.13B |
- Stock Market
- Equities
- BDSX Stock